Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Yang, J. C-H.; Ramalingam, S. S.; Kim, T. M.; Kim, S-W.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Campelo, M. R. Garcia; Felip, E.; Bazhenova, L.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Churchill, E. N.; Mehta, M.; Janne, P. A.; Zhou, C.

authors

Publication Date

  • January 1, 2021

webpage

published in

category

start page

  • S975

end page

  • S975

volume

  • 32